Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nivalis Therapeutics, Inc. | 0 | reported | 20 May 2024 | tx 20+204,488−627,892 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 31,200 | — | |
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 102,192 | — | |
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 26,922 | — | deriv |
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 70,155 | — | deriv |
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 112,500 | — | deriv |
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 109,000 | — | deriv |
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 2,635 | — | deriv |
| 20 May 2024 | OTHER | Nivalis Therapeutics, Inc. | 78,000 | — | deriv |
| 08 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 38,078 | 3.23 USD | |
| 08 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 25,000 | 6.51 USD | |
| 08 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 12,365 | 4.09 USD | |
| 08 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 9,845 | 13.20 USD | |
| 08 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 10,000 | 4.76 USD | |
| 08 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 08 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 12,365 | 0.00 USD | deriv |
| 08 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 38,078 | 0.00 USD | deriv |
| 08 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 08 May 2024 | EXERCISE | Nivalis Therapeutics, Inc. | 9,845 | 0.00 USD | deriv |
| 04 Jan 2024 | GRANT_AWARD | Nivalis Therapeutics, Inc. | 31,200 | 0.00 USD | |
| 04 Jan 2024 | GRANT_AWARD | Nivalis Therapeutics, Inc. | 78,000 | 0.00 USD | deriv |